Levonorgestrel Apofri Tafla 1,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

levonorgestrel apofri tafla 1,5 mg

apofri ab - levonorgestrelum inn - tafla - 1,5 mg

Stilnoct Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

stilnoct filmuhúðuð tafla 10 mg

sanofi-aventis norge as - zolpidemum tartrat - filmuhúðuð tafla - 10 mg

Cloxacillin Vital Pharma Nordic Stungulyfs-/innrennslisstofn, lausn 2 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cloxacillin vital pharma nordic stungulyfs-/innrennslisstofn, lausn 2 g

vital pharma nordic aps - cloxacillinum natríum - stungulyfs-/innrennslisstofn, lausn - 2 g

Postinor Tafla 1,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

postinor tafla 1,5 mg

gedeon richter plc.* - levonorgestrelum inn - tafla - 1,5 mg

Norgesic 35 mg/450 mg Tafla 35+450 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

norgesic 35 mg/450 mg tafla 35+450 mg

viatris aps - orphenadrinum cítrat; paracetamolum inn - tafla - 35+450 mg

Microgyn Tafla Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

microgyn tafla

bayer ab* - levonorgestrelum inn; ethinylestradiolum inn - tafla

Melleva Filmuhúðuð tafla 0,15 mg/0,03 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

melleva filmuhúðuð tafla 0,15 mg/0,03 mg

exeltis healthcare s.l. - levonorgestrelum inn; ethinylestradiolum inn - filmuhúðuð tafla - 0,15 mg/0,03 mg

Microstad Húðuð tafla 150 míkróg/30 míkróg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

microstad húðuð tafla 150 míkróg/30 míkróg

stada arzneimittel ag - levonorgestrelum inn; ethinylestradiolum inn - húðuð tafla - 150 míkróg/30 míkróg

Teysuno Evrópusambandið - íslenska - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafúri, gimeracil, oteracil - magaæxli - Æxlishemjandi lyf - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Kyleena Leginnlegg 19.5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

kyleena leginnlegg 19.5 mg

bayer a/s* - levonorgestrelum inn - leginnlegg - 19.5 mg